We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

22 hedge funds and large institutions have $2.85M invested in Edesa Biotech in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

108% more capital invested

Capital invested by funds: $1.37M → $2.85M (+$1.48M)

29% more funds holding

Funds holding: 17 → 22 (+5)

0.13% more ownership

Funds ownership: 0.28% → 0.42% (+0.13%)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$481K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$86.5K
3
State Street
State Street
Massachusetts
+$77.1K
4
Verition Fund Management
Verition Fund Management
Connecticut
+$75.1K
5
1WA
180 Wealth Advisors
Washington
+$27.8K

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$124K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$821K +$11.5K +296 +2%
VF
2
Virtu Financial
New York
$779K +$481K +12,368 +457%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$570K +$17.9K +460 +4%
1WA
4
180 Wealth Advisors
Washington
$156K +$27.8K +714 +33%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$115K +$86.5K +2,223 New
Northern Trust
6
Northern Trust
Illinois
$113K – – –
State Street
7
State Street
Massachusetts
$102K +$77.1K +1,982 New
Verition Fund Management
8
Verition Fund Management
Connecticut
$100K +$75.1K +1,929 New
UBS Group
9
UBS Group
Switzerland
$39K +$8.83K +227 +42%
TRCT
10
Tower Research Capital (TRC)
New York
$24K +$18.2K +468 New
FIA
11
FNY Investment Advisers
New York
$12K +$9.11K +234 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$11K +$6.11K +157 +334%
Fifth Third Bancorp
13
Fifth Third Bancorp
Ohio
$5K – – –
Barclays
14
Barclays
United Kingdom
$2K +$1.67K +43 New
Osaic Holdings
15
Osaic Holdings
Arizona
$1K – – –
Morgan Stanley
16
Morgan Stanley
New York
$1K +$1.13K +29 New
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$996 – – –
APA
18
American Portfolios Advisors
New York
$15 – – –
Stifel Financial
19
Stifel Financial
Missouri
– -$124K -3,348 Closed

EDSA Hedge Fund Activity: Q3 2021 in Review

22 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2021, worth a combined $2.85M — up 108% from $1.37M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new EDSA positions and 2 closed out — a net gain of 5 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, adding an estimated $481K. The largest seller was Stifel Financial, exiting entirely with an estimated $124K sold.

  • 22 institutional investors held Edesa Biotech (EDSA) as of Q3 2021, up from 17 in Q2 2021.
  • Funds reported $2.85M of Edesa Biotech stock for Q3 2021, up 108% quarter-over-quarter.
  • 7 funds opened new Edesa Biotech positions in Q3 2021 and 2 closed out, a net change of +5 holders.
  • The largest Edesa Biotech buyer in Q3 2021 was Virtu Financial, an estimated $481K added.
  • The largest Edesa Biotech seller in Q3 2021 was Stifel Financial, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2021.